Published in Cancer Lett on August 15, 2009
A new type of protein chip to detect hepatocellular carcinoma-related autoimmune antibodies in the sera of hepatitis C virus-positive patients. Proteome Sci (2013) 1.44
Autoantibodies to tumor-associated antigens as diagnostic biomarkers in hepatocellular carcinoma and other solid tumors. Expert Rev Mol Diagn (2010) 1.23
Kinase inhibitor Sorafenib modulates immunosuppressive cell populations in a murine liver cancer model. Lab Invest (2011) 1.22
High-throughput screening for native autoantigen-autoantibody complexes using antibody microarrays. J Proteome Res (2013) 0.93
Autoantibodies against glucose-regulated protein 78 as serological diagnostic biomarkers in hepatocellular carcinoma. Int J Oncol (2012) 0.89
Mini-array of multiple tumor-associated antigens (TAAs) in the immunodiagnosis of breast cancer. Oncol Lett (2012) 0.86
Preferential autoimmune response in prostate cancer to cyclin B1 in a panel of tumor-associated antigens. J Immunol Res (2014) 0.83
Autoimmune response to PARP and BRCA1/BRCA2 in cancer. Oncotarget (2015) 0.83
Using immunoproteomics to identify tumor-associated antigens (TAAs) as biomarkers in cancer immunodiagnosis. Autoimmun Rev (2013) 0.83
Serum autoantibody measurement for the detection of hepatocellular carcinoma. PLoS One (2014) 0.83
Autoantibody response to a novel tumor-associated antigen p90/CIP2A in breast cancer immunodiagnosis. Tumour Biol (2014) 0.83
A cancer-related protein 14-3-3ζ is a potential tumor-associated antigen in immunodiagnosis of hepatocellular carcinoma. Tumour Biol (2014) 0.81
Humoral autoimmune responses to insulin-like growth factor II mRNA-binding proteins IMP1 and p62/IMP2 in ovarian cancer. J Immunol Res (2014) 0.79
Autoantibodies against tumor-associated antigens for detection of hepatocellular carcinoma. World J Hepatol (2015) 0.79
Prognostic and diagnostic value of spontaneous tumor-related antibodies. Clin Dev Immunol (2010) 0.78
Autoantibody to MDM2: A Potential Serological Marker of Systemic Lupus Erythematosus. J Immunol Res (2015) 0.78
Using immunomic approach to enhance tumor-associated autoantibody detection in diagnosis of hepatocellular carcinoma. Clin Immunol (2014) 0.78
Overexpression of HCC1/CAPERα may play a role in lung cancer carcinogenesis. Tumour Biol (2014) 0.78
Autoantibody response to murine double minute 2 protein in immunodiagnosis of hepatocellular carcinoma. J Immunol Res (2014) 0.77
Evaluation and characterization of anti-RalA autoantibody as a potential serum biomarker in human prostate cancer. Oncotarget (2016) 0.76
Autoantibody to MDM2: A potential serological marker of primary Sjogren's syndrome. Oncotarget (2017) 0.75
Humoral autoimmune response to nucleophosmin in the immunodiagnosis of hepatocellular carcinoma. Oncol Rep (2015) 0.75
Autoantibody signatures in prostate cancer. N Engl J Med (2005) 7.56
Activation of RalA is critical for Ras-induced tumorigenesis of human cells. Cancer Cell (2005) 3.17
New paths in human cancer serology. J Exp Med (1998) 3.12
The suil suppressor locus in Saccharomyces cerevisiae encodes a translation factor that functions during tRNA(iMet) recognition of the start codon. Mol Cell Biol (1992) 3.01
Risk of cirrhosis and primary liver cancer in alpha 1-antitrypsin deficiency. N Engl J Med (1986) 2.84
The Ras branch of small GTPases: Ras family members don't fall far from the tree. Curr Opin Cell Biol (2000) 2.38
Gene expression in papillary thyroid carcinoma reveals highly consistent profiles. Proc Natl Acad Sci U S A (2001) 2.38
A novel cytoplasmic protein with RNA-binding motifs is an autoantigen in human hepatocellular carcinoma. J Exp Med (1999) 2.36
Autoantibodies to tumor-associated antigens: reporters from the immune system. Immunol Rev (2008) 2.30
Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens. Cancer Epidemiol Biomarkers Prev (2003) 2.14
Screening tests for hepatocellular carcinoma in patients with chronic hepatitis C: a systematic review. Hepatology (2002) 2.13
Antibody detection using tumor-associated antigen mini-array in immunodiagnosing human hepatocellular carcinoma. J Hepatol (2006) 2.11
Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma. Gastroenterology (2004) 2.08
RAL GTPases are linchpin modulators of human tumour-cell proliferation and survival. EMBO Rep (2003) 2.02
Cloning and characterization of a novel 90 kDa 'companion' auto-antigen of p62 overexpressed in cancer. Oncogene (2002) 1.95
Autoantibodies in pathology and cell biology. Cell (1991) 1.93
Antinuclear antibodies (ANAs): diagnostically specific immune markers and clues toward the understanding of systemic autoimmunity. Clin Immunol Immunopathol (1988) 1.90
Use of tumour-responsive T cells as cancer treatment. Lancet (2009) 1.73
Recursive partitioning as an approach to selection of immune markers for tumor diagnosis. Clin Cancer Res (2003) 1.72
Novel nuclear autoantigen with splicing factor motifs identified with antibody from hepatocellular carcinoma. J Clin Invest (1993) 1.66
Ras-dependent activation of the small GTPase Ral. Curr Biol (1998) 1.42
Signal pathways which promote invasion and metastasis: critical and distinct contributions of extracellular signal-regulated kinase and Ral-specific guanine exchange factor pathways. Mol Cell Biol (2001) 1.38
Increasing titers and changing specificities of antinuclear antibodies in patients with chronic liver disease who develop hepatocellular carcinoma. Cancer (1993) 1.37
The role of Ral A in epidermal growth factor receptor-regulated cell motility. Cancer Res (2002) 1.31
Antiangiogenic property of pigment epithelium-derived factor in hepatocellular carcinoma. Hepatology (2004) 1.22
A cell-cycle nuclear autoantigen containing WD-40 motifs expressed mainly in S and G2 phase cells. Biochem Biophys Res Commun (1995) 1.20
Pigment epithelium-derived factor (PEDF)-induced apoptosis and inhibition of vascular endothelial growth factor (VEGF) expression in MG63 human osteosarcoma cells. Life Sci (2005) 1.19
De-novo humoral immune responses to cancer-associated autoantigens during transition from chronic liver disease to hepatocellular carcinoma. Clin Exp Immunol (2001) 1.15
'Hepatoma-specific' alphafetoprotein may permit preclinical diagnosis of malignant change in patients with chronic liver disease. Br J Cancer (1997) 1.08
Mutations in the MOF2/SUI1 gene affect both translation and nonsense-mediated mRNA decay. RNA (1999) 1.07
Expression of HLA class I molecules and the transporter associated with antigen processing in hepatocellular carcinoma. Hepatology (1996) 1.07
The small G-protein RalA stimulates metastasis of transformed cells. Oncogene (2005) 1.03
The translation initiation factor, hu-Sui1 may be a target of hepatitis B X antigen in hepatocarcinogenesis. Oncogene (1999) 1.02
Biopsy diagnosis of well-differentiated hepatocellular carcinoma based on new morphologic criteria. Hepatology (1989) 1.00
Interferon-gamma-mediated growth regulation of melanoma cells: involvement of STAT1-dependent and STAT1-independent signals. J Invest Dermatol (2004) 0.95
Towards a cancer immunome database. Cancer Immun (2001) 0.94
Diversity of antinuclear antibody responses in hepatocellular carcinoma. J Hepatol (1997) 0.93
Autoantibody responses in Chinese hepatocellular carcinoma. J Clin Immunol (2002) 0.92
Serum ferritin concentration in early breast cancer. Br J Cancer (1976) 0.91
Knockdown of fibronectin induces mitochondria-dependent apoptosis in rat mesangial cells. J Am Soc Nephrol (2005) 0.86
The IGF2 receptor is a USF2-specific target in nontumorigenic mammary epithelial cells but not in breast cancer cells. J Biol Chem (2003) 0.85
Use of specific ELISA for the detection of antibodies directed against p53 protein in patients with hepatocellular carcinoma. J Clin Pathol (1996) 0.83
Serum and tumour ferritins in primary liver cancer. Gut (1978) 0.83
Identification of okadaic-acid-induced genes by mRNA differential display in glioma cells. J Biomed Sci (2000) 0.82
In the new area of noninvasive markers of hepatocellular carcinoma. J Hepatol (2006) 0.78
Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion. Cancer Cell (2009) 4.73
Increased incidence of well-differentiated thyroid cancer associated with Hashimoto thyroiditis and the role of the PI3k/Akt pathway. J Am Coll Surg (2007) 2.28
The spike protein of SARS-CoV--a target for vaccine and therapeutic development. Nat Rev Microbiol (2009) 2.23
Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens. Cancer Epidemiol Biomarkers Prev (2003) 2.14
Antibody detection using tumor-associated antigen mini-array in immunodiagnosing human hepatocellular carcinoma. J Hepatol (2006) 2.11
Recursive partitioning as an approach to selection of immune markers for tumor diagnosis. Clin Cancer Res (2003) 1.72
Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies. J Immunol (2005) 1.70
Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine. Biochem Biophys Res Commun (2004) 1.67
A comparison of treatment combinations with and without radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombus. Int J Radiat Oncol Biol Phys (2005) 1.66
Targeted inhibition of mammalian target of rapamycin signaling inhibits tumorigenesis of colorectal cancer. Clin Cancer Res (2009) 1.61
Integrating next-generation sequencing and traditional tongue diagnosis to determine tongue coating microbiome. Sci Rep (2012) 1.52
Research and development of universal influenza vaccines. Microbes Infect (2010) 1.49
QSPR/QSAR models for prediction of the physicochemical properties and biological activity of polybrominated diphenyl ethers. Chemosphere (2006) 1.46
Identification and network of outer membrane proteins regulating streptomysin resistance in Escherichia coli. J Proteome Res (2008) 1.42
Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model. Vaccine (2006) 1.36
Tumor-associated antigen arrays for the serological diagnosis of cancer. Mol Cell Proteomics (2006) 1.32
Urban environmental mercury in Changchun, a metropolitan city in Northeastern China: source, cycle, and fate. Sci Total Environ (2004) 1.28
An M2e-based multiple antigenic peptide vaccine protects mice from lethal challenge with divergent H5N1 influenza viruses. Virol J (2010) 1.26
Anti-DFS70 antibodies in 597 healthy hospital workers. Arthritis Rheum (2004) 1.26
Radiation therapy for adrenal gland metastases from hepatocellular carcinoma. Jpn J Clin Oncol (2005) 1.25
Autoantibodies to tumor-associated antigens as diagnostic biomarkers in hepatocellular carcinoma and other solid tumors. Expert Rev Mol Diagn (2010) 1.23
Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity. Virology (2009) 1.22
Preferential humoral immune response in prostate cancer to cellular proteins p90 and p62 in a panel of tumor-associated antigens. Prostate (2005) 1.19
A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV. Virol J (2013) 1.19
A critical HA1 neutralizing domain of H5N1 influenza in an optimal conformation induces strong cross-protection. PLoS One (2013) 1.18
Humoral immune response to p16, a cyclin-dependent kinase inhibitor in human malignancies. Oncol Rep (2006) 1.15
Cleavage of spike protein of SARS coronavirus by protease factor Xa is associated with viral infectivity. Biochem Biophys Res Commun (2007) 1.14
PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis. J Autoimmun (2010) 1.13
Using proteomic approach to identify tumor-associated antigens as markers in hepatocellular carcinoma. J Proteome Res (2008) 1.13
PI3K/Akt activation is critical for early hepatic regeneration after partial hepatectomy. Am J Physiol Gastrointest Liver Physiol (2008) 1.11
Using proteomic approach to identify tumor-associated proteins as biomarkers in human esophageal squamous cell carcinoma. J Proteome Res (2011) 1.11
Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry. Biochem Biophys Res Commun (2004) 1.10
Age-related sensitivity and pathological differences in infections by 2009 pandemic influenza A (H1N1) virus. Virol J (2011) 1.09
Identification of immunodominant sites on the spike protein of severe acute respiratory syndrome (SARS) coronavirus: implication for developing SARS diagnostics and vaccines. J Immunol (2004) 1.09
A recombinant vaccine of H5N1 HA1 fused with foldon and human IgG Fc induced complete cross-clade protection against divergent H5N1 viruses. PLoS One (2011) 1.08
Association of interleukin-1 gene polymorphisms with gastric cancer: a meta-analysis. Int J Cancer (2007) 1.08
Significance of autoantibodies against insulin-like growth factor II mRNA-binding proteins in patients with hepatocellular carcinoma. Int J Oncol (2005) 1.08
Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines. Virology (2005) 1.04
Pathological study on severe acute respiratory syndrome. Chin Med J (Engl) (2003) 1.04
Upregulation and redistribution of integrin alpha6beta4 expression occurs at an early stage in pancreatic adenocarcinoma progression. Mod Pathol (2007) 1.03
Recent advances in organic mechanofluorochromic materials. Chem Soc Rev (2012) 1.02
Analyses of autoantibodies against tumor-associated antigens in patients with hepatocellular carcinoma. Int J Oncol (2005) 1.02
Characterization of metaproteomics in crop rhizospheric soil. J Proteome Res (2011) 1.02
Residual efficacy of pyriproxyfen and hydroprene applied to wood, metal and concrete for control of stored-product insects. Pest Manag Sci (2009) 1.01
Hemangioma versus vascular malformation: presence of nerve bundle is a diagnostic clue for vascular malformation. Arch Pathol Lab Med (2005) 1.01
Antigenicity and immunogenicity of SARS-CoV S protein receptor-binding domain stably expressed in CHO cells. Biochem Biophys Res Commun (2009) 1.00
Identification and structural characterization of a broadly neutralizing antibody targeting a novel conserved epitope on the influenza virus H5N1 hemagglutinin. J Virol (2012) 1.00
A 219-mer CHO-expressing receptor-binding domain of SARS-CoV S protein induces potent immune responses and protective immunity. Viral Immunol (2010) 0.98
Rapid assembly of multiple-exon cDNA directly from genomic DNA. PLoS One (2007) 0.97
Development of a safe and convenient neutralization assay for rapid screening of influenza HA-specific neutralizing monoclonal antibodies. Biochem Biophys Res Commun (2010) 0.97
Autoantibodies to tumor-associated antigens as biomarkers in cancer immunodiagnosis. Autoimmun Rev (2010) 0.97
Influence of tumor thrombus location on the outcome of external-beam radiation therapy in advanced hepatocellular carcinoma with macrovascular invasion. Int J Radiat Oncol Biol Phys (2012) 0.96
Overexpression of the IGF2-mRNA binding protein p62 in transgenic mice induces a steatotic phenotype. J Hepatol (2010) 0.96
Cyclin B1 is commonly expressed in the cytoplasm of primary human acute myelogenous leukemia cells and serves as a leukemia-associated antigen associated with autoantibody response in a subset of patients. Eur J Haematol (2007) 0.95
Identification of an autoantibody panel to separate lung cancer from smokers and nonsmokers. BMC Cancer (2010) 0.94
Autoimmune response to anti-apoptotic protein survivin and its association with antibodies to p53 and c-myc in cancer detection. Cancer Detect Prev (2005) 0.94
Recombinant expression and biochemical characterization of the catalytic domain of acetylcholinesterase-1 from the African malaria mosquito, Anopheles gambiae. Insect Biochem Mol Biol (2009) 0.94
Identification of immunodominant epitopes on the membrane protein of the severe acute respiratory syndrome-associated coronavirus. J Clin Microbiol (2005) 0.94
Autoantibodies to Ca2+ binding protein Calnuc is a potential marker in colon cancer detection. Int J Oncol (2007) 0.94
A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. III. Comparative performance characteristics of academic and manufacturers' laboratories. J Rheumatol (2003) 0.93
Both viremia and cytokine levels associate with the lack of severe disease in secondary dengue 1 infection among adult Chinese patients. PLoS One (2010) 0.92
Palliative radiation therapy for pulmonary metastases from hepatocellular carcinoma. Clin Exp Metastasis (2011) 0.92
Systematic identification of the subproteome of Escherichia coli cell envelope reveals the interaction network of membrane proteins and membrane-associated peripheral proteins. J Proteome Res (2006) 0.92
Detection of human papilloma virus subtypes 16 and P16(ink4a) in invasive squamous cell carcinoma of the fallopian tube and concomitant squamous cell carcinoma in situ of the cervix. J Obstet Gynaecol Res (2009) 0.92
XRCC1 gene polymorphisms and lung cancer susceptibility: a meta-analysis of 44 case-control studies. Mol Biol Rep (2012) 0.92
Autoantibody responses in Chinese hepatocellular carcinoma. J Clin Immunol (2002) 0.92
An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus. Virol J (2010) 0.91
Genetic Polymorphisms in Long Noncoding RNA H19 Are Associated With Susceptibility to Breast Cancer in Chinese Population. Medicine (Baltimore) (2016) 0.90
EB1089 inhibits the parathyroid hormone-related protein-enhanced bone metastasis and xenograft growth of human prostate cancer cells. Mol Cancer Ther (2009) 0.90
Effects of tachyplesin on proliferation and differentiation of human hepatocellular carcinoma SMMC-7721 cells. World J Gastroenterol (2002) 0.90
Comparative sequence analyses of a new mammalian reovirus genome and the mammalian reovirus S1 genes from six new serotype 2 human isolates. Virus Genes (2008) 0.90
An analysis of trends and growth factor receptor expression of GI carcinoid tumors. J Gastrointest Surg (2009) 0.90
Loss of cell-adhesion molecule complexes in solid pseudopapillary tumor of pancreas. Mod Pathol (2007) 0.90
Antibodies to microtubule-associated protein 2 in patients with neuropsychiatric systemic lupus erythematosus. Arthritis Rheum (2004) 0.90
p62 Expression in primary carcinomas of the digestive system. World J Gastroenterol (2005) 0.90
Detection of autoantibodies to multiple tumor-associated antigens in the immunodiagnosis of ovarian cancer. Mol Med Rep (2011) 0.89
XRCC1 gene polymorphisms and esophageal squamous cell carcinoma risk in Chinese population: A meta-analysis of case-control studies. Int J Cancer (2009) 0.89